Atlas Trials

Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome

Clinical trial NCT01127503 · TERMINATED

Trial details

NCT number
NCT01127503
Sponsor
Bausch Health Americas, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Velo-cardio-facial SyndromePsychosis
Start date
2010-06-01
Primary completion
2010-11-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.